Cu-64-PSMA-I&T

Cu-64 labeled PSMA-I&T radiotracer · Curium US LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cu-64-PSMA-I&T, covering 2025-01-24 to 2025-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer [Phase 2]

See pricing